Stock LIGAND PHARMACEUTICALS INC.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Calendar Ligand Pharmaceuticals Inc. OTC Bulletin Board

Equities

US53220K1815

End-of-day quote OTC Bulletin Board
Other stock markets
- USD - Intraday chart for Ligand Pharmaceuticals Inc.
06-27 Ligand Pharmaceuticals' Partner Gets US FDA Approval for Ohtuvayre to Treat Chronic Obstructive Pulmonary Disease MT
06-18 Merck Receives FDA Approval for Capvaxive, Triggers $2 Million Payment for Ligand Pharmaceuticals MT

Chart calendar Ligand Pharmaceuticals Inc.

23dd2612e8d3fad55600ed9a7.OHiIT4yDilx3LgYcWhGkgt9TmNpRRk5ZfB0h_MWotfg.fEvcBcT73AVDd1xGImD3-5ww3YACNTk4OlFmnaDh_sFRSuAa7fXfEhRPdQ~662e92a3b6e57d340bb773a51be682eb

Upcoming events on Ligand Pharmaceuticals Inc.

04/08/2024 Q2 2024 Earnings Release (Projected)
04/11/2024 Q3 2024 Earnings Release (Projected)
05/02/2025 Q4 2024 Earnings Release (Projected)
30/04/2025 Q1 2025 Earnings Release (Projected)

Past events on Ligand Pharmaceuticals Inc.

14/06/2024 16:30 Annual General Meeting
12/06/2024 21:00 Goldman Sachs Global Healthcare Conference
28/05/2024 Craig Hallum Institutional Investor Conference
20/05/2024 Benchmark Healthcare House Virtual Conference
07/05/2024 21:30 Q1 2024 Earnings Call
07/05/2024 21:00 Q1 2024 Earnings Release
14/03/2024 14:45 Barclays Global Healthcare Conference
27/02/2024 13:30 Q4 2023 Earnings Call
27/02/2024 12:00 Q4 2023 Earnings Release
12/12/2023 15:30 Investor and Analyst Day
08/11/2023 21:30 Q3 2023 Earnings Call
08/11/2023 21:01 Q3 2023 Earnings Release
12/09/2023 05:00 H.C. Wainwright 25th Annual Global Investment Conference
08/08/2023 21:30 Q2 2023 Earnings Call
08/08/2023 21:01 Q2 2023 Earnings Release
09/06/2023 16:30 Annual General Meeting
04/05/2023 21:30 Q1 2023 Earnings Call
04/05/2023 21:01 Q1 2023 Earnings Release
22/02/2023 21:30 FY 2022 Earnings Call
22/02/2023 21:01 FY 2022 Earnings Release

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD		Released
Forecast
Spread 		120
118
1.54%		186
173
7.72%		277
270
2.73%		196
184
6.55%		131
129
1.88%
138

EBITDA
Million USD		Released
Forecast
Spread 		62,5
71,8
-12.92%		80,0
76,0
5.23%		165
157
5.05%		87,8
92,7
-5.33%		70,3
84,3
-16.62%
96,1

EBIT
Million USD		Released
Forecast
Spread 		-5,72
7,73
-174.02%		25,8
29,9
-13.58%		78,9
65,7
20.04%		3,04
-6,02
150.48%		11,9
10,7
11.81%
24,8

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		797
797
-0.08%		-10,5
-5,29
-99.33%		47,3
65,2
-27.46%		36,0
-16,9
313.18%		63,7
42,3
50.39%
122

Net income
Million USD		Released
Forecast
Spread 		629
636
-1.03%		-2,99
-2,46
-21.36%		57,6
71,9
-19.9%		-33,4
-12,9
-158.89%		52,2
32,0
62.92%
92,7

EPS
USD		Released
Forecast
Spread 		31,9
32,9
-3.05%		-0,18
-0,13
-44%		3,34
4,25
-21.37%		-1,98
-0,62
-221.95%		2,94
1,91
54.2%
5,00

Announcement Date06/02/2003/02/2117/02/2222/02/2327/02/24-

Quarterly results

Fiscal PeriodDecember 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales
Million USD		Released
Forecast
Spread 		45,7
34,2
33.56%		57,4
37,7
52.16%		66,1
38,3
72.41%		50,4
39,6
27.12%		44,0
33,5
31.1%		26,4
25,7
2.46%		32,9
27,2
20.73%		28,1
25,6
9.58%		31,0
27,9
10.94%
32,0


35,3


39,7


26,9


34,4

EBITDA
Million USD		Released
Forecast
Spread 		11,5
11,2
2.5%		22,3
4,58
386.92%		25,0
12,0
108.22%		16,1
29,0
-44.58%		28,2
27,4
2.99%		14,7
17,3
-14.81%		15,0
16,0
-6.3%		10,7
14,2
-25.02%		21,8
16,3
33.77%
21,3


25,0


28,3


15,2


23,5

EBIT
Million USD		Released
Forecast
Spread 		-9,31
-12,2
23.96%		-0,47
-21,4
97.81%		0,64
-12,1
105.24%		-20,1
3,14
-739.35%		14,2
0,28
4968.69%		-1,98
-1,29
-53.6%		-0,12
-1,97
93.79%		-3,36
-3,21
-4.55%		2,99
-1,51
297.71%
4,10


7,36


10,3


-1,11


7,14

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-20,1
-15,1
-33.55%		-0,64
-16,9
96.24%		0,86
-10,2
108.4%		24,1
3,03
696.61%		55,5
1,17
4632.51%		3,17
3,29
-3.54%		-15,3
-2,26
-580.26%		17,1
-1,71
1102.17%		113
3,04
3626.29%
8,66


11,7


14,9


-0,52


7,74

Net income
Million USD		Released
Forecast
Spread 		-15,4
-11,8
-30.89%		-0,90
-13,0
93.11%		0,40
-8,44
104.79%		-17,5
2,71
-746.08%		41,9
-1,49
2912.22%		2,29
1,80
26.94%		-12,8
-3,72
-243.96%		18,2
-1,16
1666.92%		86,1
2,36
3549.18%
6,68


8,97


11,4


-0,40


5,88

EPS
USD		Released
Forecast
Spread 		-0,91
-0,58
-57.99%		-0,05
-0,62
91.9%		0,02
-0,48
104.19%		-1,04
0,32
-430.16%		2,33
0,18
1194.44%		0,13
-0,05
388.89%		-0,74
0,05
-1685.6%		1,03
0,07
1371.43%		4,75
0,23
1995.56%
0,43


0,58


0,68







Announcement Date04/05/2208/08/2207/11/2222/02/2304/05/2308/08/2308/11/2327/02/2407/05/24-----

Upcoming sector events for Ligand Pharmaceuticals Inc.

03/07/2024 HISAMITSU PHARMACEUTICAL CO., INC.: Q1 2024 Earnings Release (Projected)
10/07/2024 HISAMITSU PHARMACEUTICAL CO., INC.: Q1 2025 Earnings Release
15/07/2024 CAMURUS AB: Q2 2024 Earnings Release
16/07/2024 GLAND PHARMA LIMITED: Q1 2025 Earnings Release (Projected)
17/07/2024 11:45 JOHNSON & JOHNSON: Q2 2024 Earnings Release
17/07/2024 JUBILANT PHARMOVA LIMITED: Q1 2025 Earnings Release (Projected)
18/07/2024 06:00 NOVARTIS AG: Q2 2024 Earnings Release
21/07/2024 GLAXOSMITHKLINE PHARMACEUTICALS LIMITED: Q1 2025 Earnings Release (Projected)
21/07/2024 ALMIRALL, S.A.: Q2 2024 Earnings Release
22/07/2024 TORRENT PHARMACEUTICALS LIMITED: Q1 2025 Earnings Release (Projected)
More events

Past sector events for Ligand Pharmaceuticals Inc.

21/06/2024 16:28 DEVA HOLDING: Q1 2024 Earnings Release
13/06/2024 22:21 EIS ECZACIBASI ILAÇ, SINAI VE FINANSAL YATIRIMLAR SANAYI VE TICARET: Q1 2024 Earnings Release
11/06/2024 06:30 BORA PHARMACEUTICALS CO., LTD.: June 2024 Sales and Revenue Release
07/06/2024 11:33 SCINOPHARM TAIWAN, LTD.: May 2024 Sales and Revenue Release
07/06/2024 10:17 LOTUS PHARMACEUTICAL CO., LTD.: May 2024 Sales and Revenue Release
30/05/2024 13:08 SUVEN PHARMACEUTICALS LIMITED: Q4 2024 Earnings Release
30/05/2024 12:00 ROIVANT SCIENCES LTD.: Q4 2023 Earnings Release
30/05/2024 07:24 MARKSANS PHARMA LIMITED: Q4 2024 Earnings Release
29/05/2024 13:00 FDC LIMITED: Q4 2024 Earnings Release
29/05/2024 10:26 JUBILANT PHARMOVA LIMITED: Q4 2024 Earnings Release
  1. Stock Market
  2. Equities
  3. LGND Stock
  4. Stock
  5. Calendar Ligand Pharmaceuticals Inc.